This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Arch Ophthalmol. 1999;117:1075-1076.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

FOR 2 DECADES, LASERS have played an important role in the management of patients with glaucoma. However, the roles of laser trabeculoplasty and laser cycloablation have been deemphasized in recent years. The Moorfield study, which randomized patients with newly diagnosed glaucoma to initial surgery, laser trabeculoplasty, or medication, suggested that initial surgery lowered intraocular pressure (IOP) and preserved visual field better than the other 2 initial approaches in a predominantly white population.¹ The success of filtration surgery with adjunctive use of antifibrotic agents reassured surgeons that extremely low IOPs would be achieved. The advent of new medications for glaucoma has tempted other clinicians to give more medications rather than proceed with any other intervention. The appropriate balance lies somewhere between the 2 extremes. On the other end of the spectrum, the development of a variety of glaucoma filtration devices has provided clinicians with an alternative to cycloablative procedures. Because of . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diode Laser Transscleral Cyclophotocoagulation as a Primary Surgical Treatment for Primary Open-angle Glaucoma
Egbert et al.
Arch Ophthalmol 2001;119:345-350.
ABSTRACT | FULL TEXT